We are live on ! Find out more
EAM

Empery Asset Management Portfolio holdings

AUM $83M
This Fund
S&P 500
This Quarter Est. Return
+2.25%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$83M
AUM Growth
-$30.4M
Cap. Flow
-$31M
Cap. Flow %
-37.32%
Top 10 Hldgs %
92.2%
Holding
43
New
12
Increased
1
Reduced
7
Closed
11

Sector Composition

Rank Sector Weight
1 Healthcare 66.69%
2 Consumer Discretionary 14.93%
3 Energy 6.57%
4 Communication Services 4.61%
5 Materials 3.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XFOR icon
1
X4 Pharmaceuticals
XFOR
$350M
$36.9M 44.5%
8,944,118
-6,987
-0.1% -$26.2K
EMPD
2
Empery Digital
EMPD
$99.8M
$12.4M 14.93%
2,930,345
DTIL icon
3
Precision BioSciences
DTIL
$195M
$10.8M 13.04%
1,968,879
-225,756
-10% -$1.04M
IMPP icon
4
Imperial Petroleum
IMPP
$211M
$3.76M 4.52%
877,645
-2,305,306
-72% -$9.21M
VENU
5
Venu Holding Corp
VENU
$137M
$3.34M 4.02%
+1,007,729
New +$5.81M
TNYA icon
6
Tenaya Therapeutics
TNYA
$177M
$2.97M 3.58%
4,286,933
-1,127,168
-21% -$832K
BSIN
7
Big Sky Industrial
BSIN
$73.8M
$1.7M 2.04%
+1,917,844
New +$1.98M
SCYX icon
8
SCYNEXIS
SCYX
$39.2M
$1.69M 2.04%
+230,978
New +$1.43M
CYN icon
9
Cyngn
CYN
$17M
$1.59M 1.92%
+957,784
New +$1.86M
JAGU
10
Jaguar Uranium Corp
JAGU
$34.7M
$1.34M 1.61%
+487,500
New +$1.14M
MSLE
11
Satellos Bioscience
MSLE
$176M
$1.3M 1.56%
+230,100
New +$2.26M
CRML icon
12
Critical Metals Corp
CRML
$942M
$1.05M 1.26%
132,039
-359,421
-73% -$4.14M
URG
13
Ur-Energy
URG
$517M
$924K 1.11%
+620,136
New +$1.01M
PMN icon
14
ProMIS Neurosciences
PMN
$132M
$766K 0.92%
+60,353
New +$900K
SLE icon
15
Super League Enterprise
SLE
$4.62M
$492K 0.59%
132,917
+28,751
+28% +$152K
TLPH icon
16
Talphera
TLPH
$69M
$441K 0.53%
590,481
-743,016
-56% -$672K
BNTC icon
17
Benitec Biopharma
BNTC
$415M
$324K 0.39%
30,440
-25,000
-45% -$289K
BCTXL
18
BriaCell Therapeutics Warrant
BCTXL
$2.65M
$309K 0.37%
+300,000
New +$318K
ABTS icon
19
Abits Group
ABTS
$3.58M
$266K 0.32%
+172,761
New +$615K
PRZO icon
20
ParaZero Technologies
PRZO
$13.8M
$218K 0.26%
+282,199
New +$325K
NSRX
21
Nasus Pharma
NSRX
$35.4M
$102K 0.12%
+45,803
New +$236K
BCTXZ
22
BriaCell Therapeutics Corp Warrant
BCTXZ
$233K
$93.3K 0.11%
666,600
NTRBW icon
23
Nutriband Inc Warrant
NTRBW
$375K
$45K 0.05%
40,218
MTEKW icon
24
Maris-Tech Ltd Warrants
MTEKW
$1.1M
$44.9K 0.05%
297,600
RTACW
25
Renatus Tactical Acquisition Corp I Warrant
RTACW
$8.09M
$23K 0.03%
50,000

Similar funds

Empery Asset Management's Q1 2026 Portfolio in Review

As of Q1 2026, Empery Asset Management held 43 positions worth $83M, down 27% from $113M the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Empery Asset Management withdrew a net $31M in Q1 2026, closing 11 positions and reducing 7 holdings. Its most notable exit was Immuneering, an estimated $17.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 67% of assets, up from 65% a quarter earlier, followed by Consumer Discretionary and Energy.

Against the trend, Empery Asset Management opened a new position in Venu Holding Corp worth $3.34M.

  • Empery Asset Management's largest Q1 2026 buy was Venu Holding Corp: 1,007,729 shares worth $3.34M.
  • Empery Asset Management added most to Super League Enterprise in Q1 2026, an estimated $152K increase.
  • Empery Asset Management's biggest Q1 2026 reduction was Imperial Petroleum, cutting an estimated $9.21M.
  • Empery Asset Management fully exited Immuneering in Q1 2026, selling an estimated $17.6M.
  • Empery Asset Management's ten largest holdings make up 92% of its $83M portfolio in Q1 2026.
  • Empery Asset Management opened 12 new positions and closed 11 in Q1 2026.
  • Empery Asset Management's portfolio value fell 27% quarter-over-quarter to $83M.

Based on Empery Asset Management's 13F filing for Q1 2026, filed 8 May 2026.